These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21189468)

  • 21. Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP.
    Egan JJ; Gronowicz G; Rodan GA
    J Cell Biochem; 1991 Jan; 45(1):101-11. PubMed ID: 1848561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of latrunculin-A on morphology and actin-associated adhesions of cultured human trabecular meshwork cells.
    Cai S; Liu X; Glasser A; Volberg T; Filla M; Geiger B; Polansky JR; Kaufman PL
    Mol Vis; 2000 Jul; 6():132-43. PubMed ID: 10930474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoskeletal coherence requires myosin-IIA contractility.
    Cai Y; Rossier O; Gauthier NC; Biais N; Fardin MA; Zhang X; Miller LW; Ladoux B; Cornish VW; Sheetz MP
    J Cell Sci; 2010 Feb; 123(Pt 3):413-23. PubMed ID: 20067993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal pigment epithelial cell function on substrates with chemically micropatterned surfaces.
    Lu L; Kam L; Hasenbein M; Nyalakonda K; Bizios R; Göpferich A; Young JF; Mikos AG
    Biomaterials; 1999 Dec; 20(23-24):2351-61. PubMed ID: 10614941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blebbistatin, a myosin II inhibitor, is photoinactivated by blue light.
    Sakamoto T; Limouze J; Combs CA; Straight AF; Sellers JR
    Biochemistry; 2005 Jan; 44(2):584-8. PubMed ID: 15641783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
    Zhang M; Rao PV
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Softening of the actin cytoskeleton by inhibition of myosin II.
    Martens JC; Radmacher M
    Pflugers Arch; 2008 Apr; 456(1):95-100. PubMed ID: 18231808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myosin-dependent actin stabilization as revealed by single-molecule imaging of actin turnover.
    Yamashiro S; Tanaka S; McMillen LM; Taniguchi D; Vavylonis D; Watanabe N
    Mol Biol Cell; 2018 Aug; 29(16):1941-1947. PubMed ID: 29847209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adhesion dynamics and substrate compliance on the shape and motility of crawling cells.
    Ziebert F; Aranson IS
    PLoS One; 2013; 8(5):e64511. PubMed ID: 23741334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two components of actin-based retrograde flow in sea urchin coelomocytes.
    Henson JH; Svitkina TM; Burns AR; Hughes HE; MacPartland KJ; Nazarian R; Borisy GG
    Mol Biol Cell; 1999 Dec; 10(12):4075-90. PubMed ID: 10588644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blebbistatin, a myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig.
    Watanabe M; Yumoto M; Tanaka H; Wang HH; Katayama T; Yoshiyama S; Black J; Thatcher SE; Kohama K
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1118-26. PubMed ID: 20164381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of extracellular matrix-cell interaction and epidermal growth factor (EGF) on EGF-receptors and actin cytoskeleton arrangement in infantile pituitary cells.
    Toral C; Solano-Agama C; Reyes-Márquez B; Sabanero M; Talamás P; González del Pliego M; Mendoza-Garrido ME
    Cell Tissue Res; 2007 Jan; 327(1):143-53. PubMed ID: 16941125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actin- and Myosin-Dependent Vesicle Loading of Presynaptic Docking Sites Prior to Exocytosis.
    Miki T; Malagon G; Pulido C; Llano I; Neher E; Marty A
    Neuron; 2016 Aug; 91(4):808-823. PubMed ID: 27537485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Myosin by Blebbistatin Derivatives: Optimization and Pharmacological Potential.
    Rauscher AÁ; Gyimesi M; Kovács M; Málnási-Csizmadia A
    Trends Biochem Sci; 2018 Sep; 43(9):700-713. PubMed ID: 30057142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel organelle map framework for high-content cell morphology analysis in high throughput.
    Schauer K; Grossier JP; Duong T; Chapuis V; Degot S; Lescure A; Del Nery E; Goud B
    J Biomol Screen; 2014 Feb; 19(2):317-24. PubMed ID: 23954930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.
    Chen G; Hou Z; Gulbranson DR; Thomson JA
    Cell Stem Cell; 2010 Aug; 7(2):240-8. PubMed ID: 20682449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Organelle Positioning Using Patterned Microdevices.
    Capmany A; Latgé B; Schauer K
    Curr Protoc Cell Biol; 2019 Mar; 82(1):e77. PubMed ID: 30431237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The actin cytoskeleton as a therapeutic target: state of the art and future directions.
    Giganti A; Friederich E
    Prog Cell Cycle Res; 2003; 5():511-25. PubMed ID: 14593746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.
    Trescos Y; Tessier E; Rougeaux C; Goossens PL; Tournier JN
    Infect Immun; 2015 Aug; 83(8):3114-25. PubMed ID: 26015478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myosin-Specific Adaptations of In vitro Fluorescence Microscopy-Based Motility Assays.
    Tripathi A; Bond C; Sellers JR; Billington N; Takagi Y
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.